1.
Zhonghua Nan Ke Xue
; 26(9): 832-837, 2020 Sep.
Artigo
em Chinês
| MEDLINE
| ID: mdl-33377709
RESUMO
Metastasis is an adverse factor in the recovery of prostate cancer, and oligometastatic prostate cancer is a disease different from localized and widespread metastatic prostate cancer. The patients may benefit from local treatment in terms of quality of life and survival time. Concerning the existing methods for the diagnosis and treatment of oligometastatic metastatic prostate cancer, researchers have advanced various views, such as "further elaboration of methodology", "specificity in the choice of treatment", and "better consideration of both local and systemic treatments". This review outlines recent advances in the studies of oligometastatic prostate cancer, hoping to provide some ideas benefiting the treatment of the malignancy.